Carisma Therapeutics Inc. (CARM)
NASDAQ: CARM
· Real-Time Price · USD
0.45
-0.10 (-17.91%)
At close: Jun 13, 2025, 3:59 PM
Carisma Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Milestones Revenue | 2M |
| Milestones Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.91M | 7.88M | 5.2M | 5.3M | 5.45M | 5.24M | 6.62M | 6.01M | 9.57M | 971K | 3.77M | 15.59M | 8.97M | 8.6M | 8.7M | 6.8M | 5.29M | 3.42M | 4.12M | 3.32M | 3.45M | 3.3M | 3.24M | 2.62M | 3.06M | 3.5M | 3.83M | 2.35M | 1.95M | 1.99M | 1.63M | 2.24M | 2.21M | 2.75M | 2.57M | 3.47M | 2.15M | 2.32M | 2.68M | 2.25M | 2.6M |
| Selling, General, and Administrative Revenue Growth | -50.41% | +51.41% | -1.92% | -2.57% | +3.91% | -20.85% | +10.20% | -37.26% | +885.99% | -74.26% | -75.80% | +73.69% | +4.40% | -1.17% | +27.83% | +28.57% | +54.77% | -16.89% | +24.02% | -3.77% | +4.55% | +1.85% | +23.73% | -14.34% | -12.59% | -8.63% | +62.70% | +20.44% | -1.66% | +21.70% | -27.22% | +1.27% | -19.59% | +7.25% | -26.07% | +61.67% | -7.42% | -13.50% | +19.31% | -13.68% | n/a |
| Research and Development Revenue | 9.16M | 15.58M | 11.33M | 15.31M | 17.46M | 19.41M | 19.55M | 18.52M | 16.64M | 18.08M | 15.56M | 14.21M | 8.77M | 7.03M | 4.96M | 7.19M | 6.05M | 5.57M | 10.2M | 4.56M | 8.87M | 5.42M | 6.61M | 7.94M | 4.69M | 4.67M | 3.37M | 2.78M | 3.25M | 3.11M | 3.62M | 2.91M | 2.87M | 2.73M | 2.75M | 3.3M | 4.63M | 8.08M | 6.75M | 6.27M | 5.24M |
| Research and Development Revenue Growth | -41.22% | +37.54% | -26.01% | -12.34% | -10.06% | -0.70% | +5.58% | +11.28% | -7.97% | +16.23% | +9.46% | +62.11% | +24.74% | +41.78% | -31.10% | +18.95% | +8.66% | -45.41% | +123.50% | -48.55% | +63.60% | -18.04% | -16.75% | +69.53% | +0.32% | +38.52% | +21.34% | -14.62% | +4.73% | -14.12% | +24.41% | +1.22% | +5.35% | -0.94% | -16.49% | -28.80% | -42.70% | +19.85% | +7.59% | +19.68% | n/a |